期刊文献+

氯吡格雷与阿司匹林治疗老年冠心病的临床疗效对比 被引量:5

Comparison of the Clinical Efficacy of Clopidogrel and Aspirin in the Treatment of Elderly Coronary Heart Disease
下载PDF
导出
摘要 目的分析比较阿司匹林与氯吡格雷治疗老年冠心病的临床疗效。方法选择老年冠心病患者96例作为研究对象,按治疗方法的不同,分为对照组(n=48例)和观察组(n=48例),对照组给予单纯阿司匹林治疗,观察组给予氯吡格雷治疗,对两组患者的临床效果进行分析比较。结果两组患者治疗前的PAG、PT、APTT指标比较差异不显著(P>0.05);观察组治疗后的PAG、PT、APTT指标分别为(31.26±5.23)%、(14.38±2.67)s、(40.23±2.34)s,优于对照组与的(43.78±8.43)%、(12.87±1.89)s、(48.51±1.67)s,差异有统计学意义(P<0.05);观察组胃黏膜出血率为4.17%,对照组胃黏膜出血率为12.50%,差异有统计学意义(P<0.05)。结论老年冠心病采取氯吡格雷治疗的临床效果显著,且安全性好。 Objective To analyze the clinical effect of aspirin and clopidogrel in the treatment of coronary heart disease. Methods 96 elderly patients with coronary heart disease (CHD) were divided into control group (n=48) and observation group (n=48 cases). The control group was treated with aspirin, and the clinical effect of the two groups was analyzed and compared. Results Two groups of patients before treatment, PT, APTT, PAG index were not significantly different (P〉0.05), PAG, APTT, PT index were (31.26±5.23) %, (14.38±2.67) s, (40.23±2.34) s, better than the control group (43.78±8.43)%, (8.43±12.87) s, (1.89±1.67) s, the difference was statistically significant (P〈0.05), the control group was 12.50%, the difference was statistically significant (P〈0.05). Conclusion Elderly patients with coronary heart disease treated with clopidogrel, the clinical effect is significant, and the safety is good.
出处 《中国继续医学教育》 2015年第25期177-178,共2页 China Continuing Medical Education
关键词 老年冠心病 阿司匹林 氯吡格雷 Elderly coronary heart disease Aspirin Clopidogrel
  • 相关文献

二级参考文献16

  • 1兰素珍.探讨心电图在冠心病诊断中的应用价值[J].当代医药论丛,2014,12(4):182-184. 被引量:6
  • 2张群英,彭建,吴新华.氯吡格雷在预防冠心病患者脑梗死中的作用[J].国外医学(脑血管疾病分册),2005,13(12):944-944. 被引量:6
  • 3W IVIOTT SD ,ANTMAN EM.Clop idogrel resistartee:a new chap ter in a fast2moving story [ J ].Circulation,2004,109 : 3064-3067.
  • 4NGUYEN TA,DIODAI JG,PHARAND C,et al.Resistance to clop idogrel:a review of the evidence [J].J Am Coll Cardiol, 2005,1945(8) : 1157-1164.
  • 5LAUWC, GURBEL PA ,WATKINS PB,et al.Contribution of hepatic cytochrome P4503A4 metabolic activity to the phenomenon of clop idogrel resistance [J ].Circulation, 2004,109 : 166-171.
  • 6NGUYEN PA,B LIDEN KP,HIATrBL,et al.Clop idogrel for coronary stenting response variability,drug resistance,and the effect of p retreatment p latelet reactivity [J].Cireulation,2003, 107 : 2908-2913.
  • 7LAU W,CARVILLED,BATESE.Clinical significance of the atorvastatin clopidogrel drug-drug interaction[J].Circulation, 2004,110(6): 66-67.
  • 8GURBEL P,DORFFLERMELLY J,IMBODEN K,et al.Stent thrombosis is associated with an impaired response to antip latelet therapy [J ].J Am Coil Cardiol, 2005,745 ( 11 ) : 1748-1752.
  • 9MULLER K, KODANIE, XUANYT, et al.Effect of aspirin on late preconditioning against my ocardial stunning in conscious rab bits[J].J Am CollCardio,2003,41 : 1183-1194.
  • 10陈灏珠.心脏病学[M].第5版.北京:人民卫生出版社,2001:1084-1085.

共引文献69

同被引文献28

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部